A systematic review and meta-analysis of 78 randomized clinical trials involving almost 74,000 people, published on Aug
Schwartz R, Kliper E, Stern N, Dotan G, Berliner S, Kesler A
HINNAO has developed a superior supplementation with a delivery mechanism that equals an infusion
Bacteriostatic water has 0.9% benzyl alcohol in it, which stops bacteria and fungus from growing
By applying QbD to the development of both ISG- and lipid-based nanoparticle formulations for intranasal drug delivery, we can ensure that the final products consistently meet quality standards, align with their desired attributes, and effectively deliver drugs through the intranasal route
A physician can prescribe it for investigational use only through a clinical trial